ANNA KETCHUM: Open Payments
NPI 1295117505 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 57 payments from 18 companies in 2025. Trend: 2023 $519 · 2024 $722 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $436 |
| Electromed, Inc. | 8 | $136 |
| Mallinckrodt Hospital Products Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Actelion Pharmaceuticals US, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Verona Pharma, Inc. | 2 | $39 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
| Ambu Inc. | 1 | $34 |
Products named: TRELEGY ELLIPTA, SMARTVEST, DUPIXENT, ACTHAR, NUCALA, UPTRAVI, Ohtuvayre, XYWAV.
Industry payments across MS — which companies pay providers there.
